• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两名接受来氟米特治疗的类风湿关节炎患者因结肠炎出现严重腹泻和体重减轻。

Debilitating diarrhoea and weight loss due to colitis in two RA patients treated with leflunomide.

作者信息

Verschueren P, Vandooren A K, Westhovens R

机构信息

Department of Rheumatology, University Hospital Leuven, Belgium.

出版信息

Clin Rheumatol. 2005 Feb;24(1):87-90. doi: 10.1007/s10067-004-1033-1. Epub 2004 Nov 23.

DOI:10.1007/s10067-004-1033-1
PMID:15565393
Abstract

Diarrhoea and weight loss are frequently reported adverse events in rheumatoid arthritis (RA) patients receiving the disease-modifying antirheumatic drug (DMARD) leflunomide. According to the available literature these side effects occur mostly during the first 6 months of treatment, are rather mild and rarely lead to treatment withdrawal. In this report, we describe the clinical, endoscopic and histologic findings in two RA patients with severe diarrhoea and important weight loss more than 12 months after starting treatment with leflunomide. In both cases the symptoms were caused by colitis, but one had ulcerative and the other microscopic colitis. Despite treatment with budesonide the complaints only improved after withdrawal of leflunomide, making a causal relationship between this drug and the pathogenesis of colitis probable. The heterogeneous histopathological findings in these two patients, however, do not allow us to draw any definitive conclusions about the mechanism by which leflunomide causes diarrhoea and weight loss in RA patients. We conclude that persistent diarrhoea or weight loss in patients taking leflunomide can be more serious than what is previously reported in the literature. In such cases leflunomide treatment should be stopped and an endoscopic examination of the colon is recommended. Given the long half-life of this drug a washout procedure with cholestyramine should be considered whenever the problem is severe or persistent.

摘要

腹泻和体重减轻是接受抗风湿药物(DMARD)来氟米特治疗的类风湿关节炎(RA)患者中经常报告的不良事件。根据现有文献,这些副作用大多发生在治疗的前6个月,相当轻微,很少导致停药。在本报告中,我们描述了两名RA患者在开始使用来氟米特治疗12个月后出现严重腹泻和显著体重减轻的临床、内镜和组织学表现。在这两个病例中,症状均由结肠炎引起,但一个是溃疡性结肠炎,另一个是显微镜下结肠炎。尽管使用布地奈德治疗,但只有在停用后症状才有所改善,这使得该药物与结肠炎发病机制之间可能存在因果关系。然而,这两名患者不同的组织病理学表现,使我们无法就来氟米特导致RA患者腹泻和体重减轻的机制得出任何明确结论。我们得出结论,服用来氟米特的患者持续腹泻或体重减轻可能比文献中先前报道的情况更严重。在这种情况下,应停止来氟米特治疗,并建议对结肠进行内镜检查。鉴于该药物的半衰期较长,每当问题严重或持续时,应考虑使用消胆胺进行洗脱程序。

相似文献

1
Debilitating diarrhoea and weight loss due to colitis in two RA patients treated with leflunomide.两名接受来氟米特治疗的类风湿关节炎患者因结肠炎出现严重腹泻和体重减轻。
Clin Rheumatol. 2005 Feb;24(1):87-90. doi: 10.1007/s10067-004-1033-1. Epub 2004 Nov 23.
2
[Persistent diarrhea and loss of weight during therapy with leflunomide].
Dtsch Med Wochenschr. 2008 Aug;133(34-35):1730-2. doi: 10.1055/s-0028-1082795.
3
[Leflunomide--the first specific disease-modifying drug against rheumatoid arthritis].
Lakartidningen. 2001 Feb 7;98(6):566-7.
4
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.来氟米特与甲氨蝶呤治疗活动性类风湿关节炎的两年双盲随机对照试验。类风湿关节炎治疗中来氟米特应用试验研究组。
Arthritis Rheum. 2001 Sep;44(9):1984-92. doi: 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B.
5
Leflunomide-associated weight loss in rheumatoid arthritis.
Arthritis Rheum. 2001 May;44(5):1048-51. doi: 10.1002/1529-0131(200105)44:5<1048::AID-ANR184>3.0.CO;2-V.
6
Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.来氟米特治疗类风湿关节炎:通过共识过程提出的建议
Rheumatology (Oxford). 2005 Mar;44(3):280-6. doi: 10.1093/rheumatology/keh500. Epub 2005 Jan 18.
7
Benefit/risk of leflunomide in rheumatoid arthritis.来氟米特在类风湿关节炎中的获益/风险
Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S95-100.
8
Leflunomide-associated infections in rheumatoid arthritis.来氟米特相关的类风湿关节炎感染
J Rheumatol. 2007 Nov;34(11):2201-3. Epub 2007 Oct 15.
9
Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.来氟米特治疗活动性类风湿关节炎:一项日常实践中的前瞻性研究。
Br J Clin Pharmacol. 2004 Jun;57(6):790-7. doi: 10.1111/j.1365-2125.2004.02075.x.
10
Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial.来氟米特10毫克与20毫克每日一次治疗活动性类风湿关节炎患者的疗效和安全性:多国双盲随机试验
Rheumatology (Oxford). 2004 Jun;43(6):744-9. doi: 10.1093/rheumatology/keh168. Epub 2004 Mar 16.

引用本文的文献

1
Simultaneous onset of Crohn's disease and Psoriasis in a Multiple Sclerosis patient treated with Teriflunomide: A novel case report highlighting potential autoimmune interactions.在用特立氟胺治疗的多发性硬化症患者中同时发生克罗恩病和银屑病:一例新病例报告,突出潜在的自身免疫相互作用
Heliyon. 2024 Feb 9;10(4):e26195. doi: 10.1016/j.heliyon.2024.e26195. eCollection 2024 Feb 29.
2
Leflunomide-induced collagenous colitis: a case report and literature review.来氟米特相关性胶原性结肠炎:一例报告及文献复习。
Clin J Gastroenterol. 2024 Feb;17(1):65-68. doi: 10.1007/s12328-023-01862-2. Epub 2023 Oct 5.
3
Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?

本文引用的文献

1
The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.来氟米特治疗活动性类风湿关节炎患者的疗效与安全性:一项五年随访研究。
Arthritis Rheum. 2003 Jun;48(6):1513-20. doi: 10.1002/art.11015.
2
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea.接受霉酚酸酯治疗的肾移植受者出现持续性无热腹泻并发糜烂性小肠结肠炎。
Transplantation. 2003 Mar 15;75(5):665-72. doi: 10.1097/01.TP.0000053753.43268.F0.
3
Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up.
药物引起的肠道炎症:病理学能否帮助鉴别炎症性肠病?
United European Gastroenterol J. 2022 Jun;10(5):451-464. doi: 10.1002/ueg2.12242. Epub 2022 May 28.
4
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations.欧洲显微镜下结肠炎指南:欧洲胃肠病学联合会和欧洲显微镜下结肠炎小组声明与建议
United European Gastroenterol J. 2021 Feb 22;9(1):13-37. doi: 10.1177/2050640620951905.
5
Leflunomide-induced colitis in association with enterocutaneous fistula in an immunosuppressed patient with renal transplant and rheumatoid arthritis.来氟米特诱发的结肠炎合并肠皮肤瘘,见于一名肾移植术后且患有类风湿关节炎的免疫抑制患者。
Clin J Gastroenterol. 2019 Aug;12(4):310-315. doi: 10.1007/s12328-019-00954-2. Epub 2019 Feb 28.
6
Chronic Diarrhea Associated with High Teriflunomide Blood Concentration.与高浓度特立氟胺血药浓度相关的慢性腹泻
Rheumatol Ther. 2016 Jun;3(1):179-185. doi: 10.1007/s40744-016-0025-3. Epub 2016 Jan 20.
7
Suppressed wound healing in a patient with rheumatoid arthritis taking leflunomide (arava).一名服用来氟米特(爱若华)的类风湿关节炎患者伤口愈合受抑制。
Perm J. 2011 Fall;15(4):70-4. doi: 10.7812/tpp/11-044.
胶原性和淋巴细胞性结肠炎:临床与组织学特征评估、治疗反应及长期随访
Am J Gastroenterol. 2003 Feb;98(2):340-7. doi: 10.1111/j.1572-0241.2003.07225.x.
4
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.在甲氨蝶呤剂量稳定的情况下,对活动性类风湿关节炎患者联合使用来氟米特治疗。一项随机、双盲、安慰剂对照试验。
Ann Intern Med. 2002 Nov 5;137(9):726-33. doi: 10.7326/0003-4819-137-9-200211050-00007.
5
Collagenous colitis associated with lansoprazole.与兰索拉唑相关的胶原性结肠炎。
J Clin Gastroenterol. 2002 Feb;34(2):164-6. doi: 10.1097/00004836-200202000-00013.
6
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine.来氟米特或柳氮磺胺吡啶长期治疗类风湿关节炎患者期间疾病进展减缓。
Scand J Rheumatol. 2001;30(3):135-42. doi: 10.1080/030097401300162897.
7
Leflunomide-associated weight loss in rheumatoid arthritis.
Arthritis Rheum. 2001 May;44(5):1048-51. doi: 10.1002/1529-0131(200105)44:5<1048::AID-ANR184>3.0.CO;2-V.
8
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.来氟米特与甲氨蝶呤治疗类风湿关节炎的疗效及安全性比较。
Rheumatology (Oxford). 2000 Jun;39(6):655-65. doi: 10.1093/rheumatology/39.6.655.
9
Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon.结肠中非甾体抗炎药所致病变的临床、内镜及组织学表现谱
Dis Colon Rectum. 2000 May;43(5):685-91. doi: 10.1007/BF02235589.
10
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.来氟米特与安慰剂和甲氨蝶呤治疗活动性类风湿关节炎的比较。来氟米特类风湿关节炎研究小组。
Arch Intern Med. 1999 Nov 22;159(21):2542-50. doi: 10.1001/archinte.159.21.2542.